Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

EMA: UK Drugmakers Are Behind Schedule on Brexit Preparedness

  • Post author:Sam
  • Post published:August 9, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The European Medicines Agency expressed “serious concerns” about drugmakers’ preparedness for the UK’s departure from the European Union in a new report. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingEMA: UK Drugmakers Are Behind Schedule on Brexit Preparedness

FDA Drafts Guidance for Inhaled Nicotine-Containing Drugs

  • Post author:Sam
  • Post published:August 9, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The FDA unveiled new draft guidance on nonclinical testing of orally-inhaled drug products that contain nicotine — and Commissioner Scott Gottlieb said the agency plans to release follow-up guidelines later…

Continue ReadingFDA Drafts Guidance for Inhaled Nicotine-Containing Drugs

Survey Shows U.S. Trust in Pharma Plummets Amid Rising Prices

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

Americans’ trust in drugmakers plunged in the past year to the lowest level since Edelman launched its annual Trust Barometer survey five years ago. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingSurvey Shows U.S. Trust in Pharma Plummets Amid Rising Prices

FDA Issues Final Guidance for ANDA Amendments Under GDUFA II

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The FDA released final guidance spelling out its review goals for amendments to abbreviated new drug applications and prior approval supplements under GDUFA II. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingFDA Issues Final Guidance for ANDA Amendments Under GDUFA II

FDA Issues Two Guidances on Payor Communications, Non-Label Information

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The FDA published two final guidances clarifying the information drugmakers can provide to payors and what non-label information they can communicate. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingFDA Issues Two Guidances on Payor Communications, Non-Label Information

FDA Issues Advice on Limited Population Pathway for Antimicrobials

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The FDA released draft guidance for sponsors who want to use the agency’s limited population pathway for antibacterial and antifungal drugs. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingFDA Issues Advice on Limited Population Pathway for Antimicrobials

EMA, FDA Officials Discuss Mutual Recognition, Generics

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

Representatives from the FDA and the European Medicines Agency discussed further opportunities for collaboration in their 2018 annual meeting. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingEMA, FDA Officials Discuss Mutual Recognition, Generics

EMA Proposes Single Clinical Guide for Bacterial Infection Treatments

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

The European Medicines Agency proposes to merge two guidances on clinical evaluations of bacterial infection treatments to reflect the latest scientific advice from its Committee for Medicinal Products for Human…

Continue ReadingEMA Proposes Single Clinical Guide for Bacterial Infection Treatments

FDA Reports Challenging Year for Drug Shortages

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

In its fifth annual drug shortage report to Congress, the FDA called 2017 “a challenging year” with shortages up again from 2016 despite a steady overall improvement since 2011. Source:…

Continue ReadingFDA Reports Challenging Year for Drug Shortages

TGA Adjusts Shortage Reporting Window Based on Feedback

  • Post author:Sam
  • Post published:July 11, 2018
  • Post category:International Pharmaceutical Regulatory Monitor

Australia’s Therapeutic Goods Administration updated its plan for mandatory drug shortage reporting based on public comments in response to an April request. Source: International Pharmaceutical Regulatory Monitor

Continue ReadingTGA Adjusts Shortage Reporting Window Based on Feedback
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.